Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in the delivery of innovative, non-opioid pain therapies to transform the lives of patients, today announced the granting of inducement ...

While New Orleans prepares for the excitement of the big game, it’s important to remember that sports injuries aren’t limited to the professionals. High school athletes, weekend warriors, and generall ...

DURECT Corporation (Nasdaq: DRRX) today announced that James E. Brown, President and Chief Executive Officer, will present at ...

About Robbins LLP: A recognized leader in shareholder rights litigation, the attorneys and staff of Robbins LLP have been dedicated to helping shareholders recover losses, improve corporate governance ...

Hastings and Andreas Wicki, PhD Retire from Board of Directors -- PARSIPPANY, N.J., Jan. 30, 2025 (GLOBE NEWSWIRE) -- Pacira ...

H.C. Wainwright analyst Ed Arce maintained a Hold rating on Durect (DRRX – Research Report) today. The company’s shares opened today at ...

DURECT Corporation (Nasdaq: DRRX) today announced the publication of a peer-reviewed article on the AHFIRM trial data in NEJM ...

OncoZenge AB (publ) (“OncoZenge” or the “Company”) announces that the Company has entered into an investment agreement (the “Investment Agreement”)whereby the Chinese investor Sichuan Yangtian ...

Another child "almost died" after suffering a severe reaction to Bupivacaine, an anaesthetic used to numb an area of the body during surgery. After searching his car, cops found a rusty hook with ...

Through his work as a clinical fellow in paediatric surgery at the University Hospital Southampton NHS Foundation Trust, he was able to source the anaesthetic Bupivacaine Hydrochloride. He continued ...

Through his work as a clinical fellow in paediatric surgery at the University Hospital Southampton NHS Foundation Trust, he was able to source the anaesthetic Bupivacaine Hydrochloride.